For clean air and containment manufacturer, Envair Technology, this journey began after the merger of two longstanding businesses (Envair and TCS).
This evolution prompted a wider review of its operations. The creation of the new entity led to a period of consolidation that saw the workforce come together at a new factory site in Greater Manchester.
Although this was primarily motivated by a desire to bring the company’s R&D function under one roof, it also provided an opportunity to examine how the business was structured and explore how a more focused approach to ESG could shape its future direction.
In this article, Helen Finney, Finance Director at Envair Technology, explains how the company’s commitment to ESG has improved operational performance, strengthened its position in the pharmaceutical supply chain and helped to build a more resilient business.
She also shares practical examples for other manufacturers looking to make sustainability part of their wider business strategy.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.
